Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2021
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
0
Like
Facebook
Tweet this
Print
Sandra Tong, MD
Rigel Pharmaceuticals, Inc.
Disclosure:
Rigel Pharmaceuticals, Inc.
(Employee, Shareholder)
Poster(s):
561 - Phase 3 Trial of Fostamatinib for the Treatment of COVID-19: Repurposing an Immunomodulatory Drug Previously Approved for Immune Thrombocytopenia
